Page last updated: 2024-11-03

propafenone and Porphyria, Variegate

propafenone has been researched along with Porphyria, Variegate in 1 studies

Propafenone: An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity.
propafenone : An aromatic ketone that is 3-(propylamino)propane-1,2-diol in which the hydrogen of the primary hydroxy group is replaced by a 2-(3-phenylpropanoyl)phenyl group. It is a class 1C antiarrhythmic drug with local anesthetic effects, and is used as the hydrochloride salt in the management of supraventricular and ventricular arrhythmias.

Porphyria, Variegate: An autosomal dominant porphyria that is due to a deficiency of protoporphyrinogen oxidase (EC 1.3.3.4) in the LIVER, the seventh enzyme in the 8-enzyme biosynthetic pathway of HEME. Clinical features include both neurological symptoms and cutaneous lesions. Patients excrete increased levels of porphyrin precursors, COPROPORPHYRINS and protoporphyrinogen.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rodríguez-Suárez, S1
García-Morillo, S1
Gómez-Morales, L1
Romero-Rodriguez, N1
Beltran-Romero, L1
Gonzalez-Estrada, A1

Other Studies

1 other study available for propafenone and Porphyria, Variegate

ArticleYear
Variegate porphyria and atrial fibrillation: acute attack induced by propafenone.
    Revista espanola de cardiologia (English ed.), 2012, Volume: 65, Issue:5

    Topics: Adult; Anti-Arrhythmia Agents; Atrial Fibrillation; Humans; Inappropriate ADH Syndrome; Male; Porphy

2012